Tong et al. demonstrated that POU3F3 facilitates cisplatin resistance in ESCC by transforming normal fibroblasts (NFs) into cancer-associated fibroblasts (CAFs). The gene discussed is POU3F3; the disease is esophageal squamous cell carcinoma.